08:00 | Registration |
| Session: Novel Approaches and Technology in Metabolomics |
| |
09:30 | Towards in situ Spatial Metabolomics Seetharaman Vaidyanathan, Lecturer, University of Sheffield, United Kingdom
We are developing secondary ion mass spectrometry imaging for in situ spatial metabolomics to capture contextual intra- and inter-cellular spatio-temporal metabolite localisations. The challenges of the current methodologies and its potential developmental scope will be discussed, in the context of other techniques currently available. |
10:00 | Advances in the Synthesis and Analysis of Chiral Central Metabolites Roland Wohlgemuth, Senior Scientist, Sigma-Aldrich , Switzerland
New pathway-specific analytical separation methods, new chiral analytical methodologies as well as the inherent chirality of biocatalysts have been key success factors for the development of new biocatalytic reactions. This has enabled the synthesis and analysis of central metabolites which up to now have been difficult to access. These newly available metabolites have found useful applications in various metabolomics areas ranging from renewable energy, plant and microbial metabolomics to biomedical and pharmaceutical research. |
10:30 | Coffee Break and Networking in the Exhibition Hall |
11:15 | | Keynote Presentation Addressing the Fundamental Challenges in Ecotoxicology Head-On Using High Resolution Mass Spectrometry Based Metabolomics Mark Viant, Professor of Metabolomics, Birmingham University, United Kingdom
This presentation will demonstrate the capabilities of high resolution mass spectrometry based metabolomics within ecotoxicology, including discovering molecular biomarkers that can predict whole animal fitness and identifying a genuinely novel mode-of-toxicity of a widely used metal oxide nanoparticle. |
|
12:00 | Ion-Mobility Edited Mass Spectrometry and its Application to Metabolic Profiling John Shockcor, Director of Metabolic Profiling, Waters Corp., United States of America
This presentation will describe the many novel uses of Ion-Mobility in metabolomics and lipidomics. |
12:30 | Technology Spotlight: Technology Spotlight Using Metabolomics to Study Malaria Steve Fischer, Senior Applications Chemist, Agilent Technologies Life Sciences Group
We apply a metabolomics study to malaria infected erythrocytes to show how a discovery of a Biomarker, and its identity can be confirmed. We also show how pathway analysis can both help with the data mining and facilitate understanding of the biological system. |
12:45 | Lunch and Networking in the Exhibition Hall |
13:30 | Poster Viewing Session |
14:15 | Metabolomics as a Platform for High-Throughput Biomarker Discovery in Cancer Aalim Weljie, Research Assistant Professor, University of Calgary, Canada
Data will be presented from cohorts of pancreatic, colon and brain tumors patients. Analysis of these biomarkers is performed using a pattern-driven approach, and as such analytical techniques which are both quantitative and high-throughput are favoured. The outcome is information with respect to a ‘biopattern’ of disease without the requirement for comprehensively attempting to characterize the entire metabolome. Furthermore, the resulting multivariate data is characterized by concerted changes in multiple markers, in contrast with traditional biomarker-driven approaches that rely on single markers. Finally, several challenges in the evolution of the field will be discussed, including interpreting coherent biological meaning from a combination of both NMR and MS data, and reliable assessment of candidate markers using multivariate statistics. |
14:45 | Metabolomic Biomarkers of Hypoxic Ischaemic Encephalopathy and Perinatal Asphyxia in Umbilical Cord Blood David Broadhurst, Assistant Professor of Biostatistics, University of Alberta, Canada
Peri-natal hypoxic ischemic encephalopathy (HIE) is a condition that occurs when the newborn brain is deprived of an adequate oxygen supply around the time of delivery, and can lead to clinical signs of cerebral injury. Here we present a DI-MS/MS metabolic profiling biomarker study of umbilical cord blood with the ultimate aim of producing quick, cheap, reproducible, non-user dependent mass spectrometer based method for quantifying severity of HIE and enabling rapid therapeutic intervention. |
15:15 | Coffee Break and Networking in the Exhibition Hall |
16:00 | Session: Disease in Metabolomics |
16:00 | | Keynote Presentation Metabolic Profiling of Physiological and Pathological Processes Elaine Holmes, Professor, Imperial College London, United Kingdom
Metabolic profiling strategies for analyzing biosamples, encompassing high-resolution spectroscopic methods in combination with multivariate statistical modelling tools will be discussed with particular emphasis on accommodating extraneous variation and optimizing biomarker recovery. |
|
16:30 | Application of Oxylipin Profiling as Part of a Systems-Based Approach to Investigating Inflammatory Disease Craig Wheelock, Associate Professor, Karolinska Institutet, Sweden
Oxylipins (e.g., eicosanoids and resolvins) are lipid mediators with well-known biological roles in a number of inflammatory diseases including asthma, COPD and atherosclerosis. These compounds have defined roles in the etiology of the inflammatory process and its subsequent resolution. Systems biology studies focus on the integration of multiple omics-based platforms towards the goal of understanding mechanisms in disease onset, progression and potential resolution. We will provide examples of the application of oxylipin profiling using UPLC-MS/MS methods from multiple biological matrices as a key component of an overall systems biology strategy |
17:00 | Lipidomics in Life Style Associated Diseases Ivana Bobeldijk-Pastorova, Senior Project Manager and Scientist, TNO Triskelion B V, Netherlands
Lipid classes important for lifestyle diseases are analyzed by LC-MS based methods in biological matrices. Different requirements are needed with respect to sample work-up, sensitivity and ionization. Overview of the methods, their strengths and weaknesses and applications will be presented. |
17:30 | Drinks Reception |